Financials IM Cannabis Corp. Nasdaq

Equities

IMCC

CA44969Q3070

Pharmaceuticals

Market Closed - Nasdaq 04:30:01 2024-05-10 pm EDT 5-day change 1st Jan Change
0.7159 USD -4.55% Intraday chart for IM Cannabis Corp. -19.53% +100.53%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 49.55 399 287.7 9.84 6.161 14.2 -
Enterprise Value (EV) 1 49.55 399 287.7 9.84 6.161 14.2 14.2
P/E ratio - - - - - - -
Yield - - - - - - -
Capitalization / Revenue 5.46 x 25.1 x 5.3 x 0.18 x 0.13 x 0.28 x 0.22 x
EV / Revenue 5.46 x 25.1 x 5.3 x 0.18 x 0.13 x 0.28 x 0.22 x
EV / EBITDA -27.3 x -71.3 x -13.1 x -0.86 x -0.77 x -3.38 x -
EV / FCF - - -7,387,347 x -692,887 x - - -
FCF Yield - - -0% -0% - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 3,644 3,974 6,818 7,570 13,394 13,394 -
Reference price 2 13.60 100.4 42.20 1.300 0.4600 1.060 1.060
Announcement Date 4/20/20 4/23/21 3/31/22 3/29/23 3/28/24 - -
1CAD in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 9.074 15.89 54.3 54.34 48.8 50.45 64.46
EBITDA 1 -1.814 -5.592 -22.03 -11.49 -7.97 -4.2 -
EBIT 1 - - -38.39 -30.79 -12.79 -10.85 -5.11
Operating Margin - - -70.7% -56.67% -26.21% -21.51% -7.93%
Earnings before Tax (EBT) 1 - - -18.01 -26.06 -9.457 -11.83 -
Net income 1 - - -18.52 -188.9 -9.498 -10.3 -
Net margin - - -34.1% -347.64% -19.46% -20.41% -
EPS - - - - - - -
Free Cash Flow - - -38.95 -14.2 - - -
FCF margin - - -71.73% -26.14% - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 4/20/20 4/23/21 3/31/22 3/29/23 3/28/24 - -
1CAD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q2 2024 Q3 2024 Q4
Net sales 1 20.03 23.57 23.82 14.17 14.46 13.17 13.21 12.37 10.7 12.16 13.08 13.93
EBITDA 1 -8.278 -4.504 -4.624 -3.666 -1.884 -1.284 -0.499 -1.293 -4.251 -1.2 -1 -0.7
EBIT 1 -11.72 -11.55 -11.64 -5.526 -10.71 2.973 -1.752 -2.259 -5.165 -2.412 -2.184 -1.994
Operating Margin -58.53% -49% -48.89% -39% -74.05% 22.57% -13.27% -18.26% -48.28% -19.84% -16.69% -14.31%
Earnings before Tax (EBT) 1 -12.16 -10.99 -20.16 -4.328 -9.76 0.028 -3.866 -2.011 -2.699 -2.655 -2.427 -2.237
Net income 1 -12.49 -9.452 -18.98 -127.8 -33.03 0.309 -3.459 -2.15 -3.289 -2.7 -2.5 -2.2
Net margin -62.35% -40.1% -79.67% -901.82% -228.39% 2.35% -26.19% -17.38% -30.74% -22.21% -19.11% -15.79%
EPS - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - -
Announcement Date 3/31/22 5/12/22 8/15/22 11/14/22 3/29/23 5/15/23 8/14/23 11/13/23 3/28/24 - - -
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - -39 -14.2 - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - 2.62 4.58 - - - -
Capex / Sales - 16.49% 8.43% - - - -
Announcement Date 4/20/20 4/23/21 3/31/22 3/29/23 3/28/24 - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.06 CAD
Average target price
3.45 CAD
Spread / Average Target
+225.47%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMCC Stock
  4. IMCC Stock
  5. Financials IM Cannabis Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW